TAUSCHER MARK R 4
4 · AdvanSource Biomaterials Corp · Filed Dec 6, 2019
Insider Transaction Report
Form 4
TAUSCHER MARK R
Director
Transactions
- Exercise of In-Money
Common Stock
2019-12-05$0.06/sh+50,000$3,000→ 50,000 total - Exercise of In-Money
Common Stock
2019-12-05+350,000→ 400,000 total
Footnotes (2)
- [F1]Shares acquired through exercise of options granted pursuant to the 2003 Stock Option Plan at an exercise price of $0.06 per share i consideration of cash.
- [F2]Shares acquired from the exercise of options pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 500,000 shares of the Company's common stock at an exercise price of $0.06 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 350,000 shares, net.